# Molgramostim Nebulizer Solution Expanded Access Program Protocol

> **NCT06546098** · — · AVAILABLE · sponsor: **Savara Inc.**

## Conditions studied

- Autoimmune Pulmonary Alveolar Proteinosis

## Interventions

- **DRUG:** Molgramostim nebulizer solution

## Key facts

- **NCT ID:** NCT06546098
- **Lead sponsor:** Savara Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546098, "Molgramostim Nebulizer Solution Expanded Access Program Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*